In another study, antisense oligonucleotides targeting receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in ApoE−/− mice identified the inflammatory role of RIPK1 in atherosclerosis and suggested RIPK1 as a potential future therapeutic target to limit atherosclerotic inflammation [92]. Here, RIPK1 is linked to atherosclerosis.